For 40 years, we’ve helped scientists harness the full potential of biology with next-generation technology. Here we share the latest in automated, end-to-end solutions that span research disciplines to advance scientific discovery and improve the quality of human life worldwide.
3D Cell Culture In Vitro Modeling Explores New Depths
Organoids and organ-on-a-chip models are becoming mainstream tools for screening applications and for precision and regenerative medicine
This July GEN cover story explores the benefits of organoids and organ-on-a-chip models for screening applications as well as precision and regenerative medicine.
Molecular Devices Vice President for Strategy and Innovation Shantanu Dhamija explains that an ecosystem of solutions and collaborations with industry partners is necessary to best support customers on their 3D biology journey.
Molecular Devices’ Angeline Lim weighs in with ways AI-enabled image analysis software uncovers more insights while healing the pains of a traditional, manual approach. She’s joined in the conversation by X-Chem, Inc.'s Noor Shaker, Charles River Laboratories' Grant Wishart, and Insilico Medicine's Alex Zhavoronkov.
Discover the critical role of microplate readers in cancer research with our comprehensive eBook
Dive deep into how these versatile tools are used to understand the intricate biology of cancer, devise innovative diagnostic techniques, and accelerate the development of potential drug candidates.
Whether you're a seasoned researcher or new to the field, this resource will offer valuable insights to enhance your work in the fight against cancer. Stay on the cutting edge of cancer research and development.
Revolutionize Food Coloring: Automated Screening of Microalgae Metabolism for Natural Dyes
Our latest application note, in partnership with Fermentalg®, explores the fascinating potential of microalgae pigments for the food and beverage industry.
Unveil the development of a vibrant and sustainable pigment, known as BLUE ORIGINS®, derived from the extraordinary metabolism of Galdieria sulphuraria.
Discover the friendly and versatile patch-clamp analysis with Axon pCLAMP 11
Discover the power of Axon™ pCLAMP™ Software Suite: the most widely used and the most cited electrophysiology program for voltage-clamp, current-clamp, and patch-clamp experiments. It includes Clampex 11 for data acquisition, AxoScope 11 for background recording, Clampfit 11 for data analysis, and the new optional Advanced Analysis Module for more sophisticated and streamlined analysis.
Check out all the features below to learn how you can perform sophisticated and efficient experiments and gain actionable insights from your data.
Generate application-specific, high-content imaging and analysis
High-content imaging provides flexible scalability that makes it easy to evolve your workflow alongside your research. And while a fast camera and an efficient imaging system can streamline image acquisition, the analysis and data handling of these images can create a bottleneck in your research protocols.
In this eBook, we feature several useful case studies highlighting different image analysis solutions and protocols to mitigate these challenges.
Learn about the good lab and manufacturing processes essential to successful drug discovery, development, and production
In this podcast, Tim Bolus, Compliance Program Manager at Molecular Devices, provides an in-depth exploration of the regulatory landscape of drug discovery and development. He examines the good lab and manufacturing processes essential to successful drug discovery, development, and production.
Check our our new Clone Screening page on LinkedIn!
Introducing our new pageMolecular Devices Clone Screening, dedicated to sharing the latest cutting-edge insights and groundbreaking discoveries in synthetic biology, monoclonality, gene editing, and cell line development.
Follow us to stay at the forefront of this dynamic field and keep your finger on the pulse of scientific advancement!
Please be advised that this email may contain confidential information. If you are not the intended recipient, please notify us by email by replying to the sender and delete this message. The sender disclaims that the content of this email constitutes an offer to enter into, or the acceptance of, any agreement; provided that the foregoing does not invalidate the binding effect of any digital or other electronic reproduction of a manual signature that is included in any attachment.